Company / Operating Income per Share
Abbott Laboratories Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$4.60
FY2025
5-year range
$2.54 / $4.71
FY2021-FY2025
Trend
+19.0%
vs FY2024
Sector context
#43 of 154
Health Care
What the data says
At $4.60, Abbott Laboratories's operating income per share ranks #43 of 154 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $1.70 in FY2016 to $4.71 in FY2023.
Based on SEC 10-K filings.
4.60 in FY2025 with a 5-year CAGR of +17.4%.
Declined from $4.71 to $4.60 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +15.4%
- 5-Year CAGR
- +17.4%
- 10-Year CAGR
- -
Sector benchmark
#43 of 154 in Health CareTop 28% of 154This company $4.60 Sector average $4.25
▼
+8.2% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 19.0% year-over-year.
- Ranks #43 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2023.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.60 | +19.0% |
| FY2024 | $3.87 | -17.8% |
| FY2023 | $4.71 | +57.0% |
| FY2022 | $3.00 | +17.9% |
| FY2021 | $2.54 | +23.4% |
| FY2020 | $2.06 | -20.4% |
| FY2019 | $2.59 | +27.0% |
| FY2018 | $2.04 | +7.2% |
| FY2017 | $1.90 | +11.8% |
| FY2016 | $1.70 | +25.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026